読み込み中
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
前日終値
$68.89
+$2.20 · +3.30%
時間外
$68.89
$0.00 · 0.00%
10月9日 16:12 ET
日中の時刻はETです。市場データは遅延する場合があります。
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
日中レンジ
現在 $68.89
52週レンジ
現在 $68.89
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
買い
バリュエーション
97
大幅な割安
センチメント
69
強気
リスク
51
やや高いリスク
モメンタム
41
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
日中レンジ
現在 $68.89
52週レンジ
現在 $68.89
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 9.12億 USD | 8.03億 USD | 6.25億 USD | 4.08億 USD | 2.33億 USD |
| 売上原価 | 1.33億 USD | 1.23億 USD | 9657.6万 USD | 6611.5万 USD | 3327.9万 USD |
| 粗利益 | 7.79億 USD | 6.8億 USD | 5.28億 USD | 3.42億 USD | 2億 USD |
| 研究開発 | 1.03億 USD | 1.14億 USD | 1.17億 USD | 6864.5万 USD | 3735万 USD |
| 販売・一般管理 | 6.25億 USD | 5.3億 USD | 4.52億 USD | 3.21億 USD | 2.03億 USD |
| 営業費用 | 7.28億 USD | 6.44億 USD | 5.68億 USD | 3.89億 USD | 2.4億 USD |
| 受取利息 | 1753.6万 USD | 2324.7万 USD | 2056万 USD | 505万 USD | 12.5万 USD |
| 支払利息 | 13.7万 USD | 2.2万 USD | — | 167.7万 USD | 212.8万 USD |
| 減価償却費と償却費 | 1395.7万 USD | 655万 USD | 284.6万 USD | 185.8万 USD | 121.8万 USD |
| 営業利益 | 5095.4万 USD | 3608.3万 USD | −4027.1万 USD | −4759.2万 USD | −3985万 USD |
| 純利益 | 1.45億 USD | 5350.9万 USD | −2115.3万 USD | −4488.1万 USD | −4204.2万 USD |
会社概要が更新されました 2026年10月10日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$62.55
下落余地（9.20%）この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI5758.22万0.00%2.3兆 USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM5086.87万0.06%782.66億 USD0.19%$278.94+0.49%
Vanguard Morningstar Small-Cap ETFVB4172.08万0.02%1853億 USD0.03%$289.48+0.64%
Vanguard Morningstar Small-Cap Growth ETFVBK2390.62万0.05%447億 USD0.05%$344.74+1.22%
Vanguard Extended Market ETFVXF1923.8万0.02%954億 USD0.05%$235+0.80%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM1764.37万0.11%158.4億 USD0.03%$53.45+0.17%
iShares Russell 2000 Growth ETFIWO1549.34万0.11%139.72億 USD0.24%$356.78+0.94%
Principal U.S. Small-Cap Multi-Factor ETFPSC1212.56万0.45%27億 USD0.38%$67.70+0.61%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Growth ETFVBKVanguard Extended Market ETFVXFState Street SPDR Portfolio S&P 600 Small Cap ETFSPSMiShares Russell 2000 Growth ETFIWOPrincipal U.S. Small-Cap Multi-Factor ETFPSCAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
